| Anthrax |
| References |
Acha, P.N. and B. Szyfres (Eds.). 1989. Zoonoses and Communicable Diseases Common to Man and Animals. Pan American Health Organization; Washington, D.C.
Anonymous. 2001. Considerations for distinguishing influenza-like illness from inhalational anthrax. M.M.W.R. 50:984-986.
Bell, D.M., P.E. Kozarsky and D.S. Stephens. 2002. Clinical issues in the prophylaxis, diagnosis and treatment of anthrax. Emerg. Infect. Dis. 8:222-225.
Benenson, A.S. (Ed.). 1995. Control of Communicable Diseases Manual. American Public Health Assoc.; Washington, D.C.
Blendon, R.J. et al. 2002. The impact of anthrax attacks on the American public. Medscape General Med. 4: http://www.medscape.com/view article/430197.
Bradley, K.A. et al. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-229.
Brookmeyer, R. and N. Blades. 2002. Prevention of inhalational anthrax in the U.S. outbreak. Science 295:1861.
Brossier, F., M. Levy and M. Mock. 2002. Anthrax spores make an essential contribution to vaccine efficacy. Infect. Immun. 70:661-664.
Brown, K. 2001. A "sure killer" yields to medicine. Science 294:1813-1814.
Bush, L.M. et al. 2001. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N. Eng. J. Med. 345:1607-1610.
Coker, P.R. et al. 2003. Bacillus anthracis virulence in guinea pigs vaccinated with anthrax vaccine adsorbed in linked to plasmid quantities and clonality. J. Clin. Microbiol. 41:1212-1218.
Dixon, T.C et al. 1999. Anthrax. N.
Eng. J. Med. 341:815-826.
Duesbery, N.S. et al. 1998. Proteolytic inactivation of
MAP-kinase-kinase by anthrax lethal factor. Science 280:734- 737.
Enserink, M. and E. Marshall. 2002. New anthrax vaccine gets a green light. Science 296:639-640.
Guillemin, J. 1999. Anthrax: the Investigation of a Deadly Outbreak. U. of CA Press, Berkeley.
Hunter, L., W. Corbett and C. Grindem. 1989. Anthrax. J.A.V.M.A. 194:1028-1031.
Inglesby, T.V. et al. 1999. Anthrax as a biological weapon. J.A.M.A. 281:1735-1745.
Jernigan, J.A. et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7:933-944.
Kanafani, Z.A. et al. 2003. Endemic gastrointestinal anthrax in 1960s Lebanon: clinical manifestations and surgical findings. Emerg. Infect. Dis. 9:520-525.
Kassenberg, H. et al. 2000. Human ingestion of Bacillus anthracis-contaminated meat - Minnesota, August 2000. M.M.W.R. 49:813-816.
Keim, P. et al. 2001. Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan. J. Clin. Microbiol. 39:4566-4567.
Lew, D. 1995. Bacillus anthracis (anthrax), in: Principles and Practice of Infectious Diseases (Eds. G.L. Mandel, J.E. Bennett and R. Dolin), pp. 1885-1889. Churchill Livingston, Inc.; New York, NY.
Lusis, P. and N. Smart. 1996. Bovine anthrax in eastern Ontario. Can. Vet. J. 37:747.
Marshall, E. 2000. DOD retreats on plan for anthrax vaccine. Science 289:382-383.
Meselson, M. et al. 1995. The Sverdlovsk anthrax outbreak of 1979. Science 266:1202-1208.
Pipkin, A.B. 1990. Anthrax, in: Large Animal Internal Medicine (Ed. B. Smith), pp. 1116-1118. C.V. Mosby Co.; St. Louis, MO
Redmond, C. et al. 1997. Experimentally assessed public health risks associated with pigs from farms experiencing anthrax. Vet. Rec. Sept. 6:244-247.
Roche, K.J. et al. 2001. Cutaneous anthrax infection. N. Eng. J. Med. 345:1611.
Sirisanthana, T. and A.E. Brown. 2002. Anthrax of the gastrointestinal tract. Emerg. Infect. Dis. 8:649-651.
Swartz, M.N. 2001. Recognition and management of anthrax - an update. N. Eng. J. Med. 345:1621-1626.
Takahashi, H. et al. 2004. Bacillus anthracis incident, Kameido, Tokyo, 1993. Emerg. Infect. Dis. 10:117-120.
Timoney, J.F. et al. 1988. Hagan and Brunner's Microbiology and Infectious Diseases of Domestic Animals, pp. 206-211. Comstock Publishing Assoc.; Ithaca, NY.
Tucker, J.B. 2000. Solving the Sverdlovsk mystery. Science 287:812.
Whitney, E.A.S. et al. 2003. Inactivation of Bacillus anthracis spores. Emerg. Infect. Dis. 9:623-627.
|
|
|